News & Events

Client News

16 December 2020
Prilenia Therapeutics - Additional analyses of Efficacy and Safety of Pridopidine for Huntington’s Disease demonstrate positive effect on functional capacity

15 December 2020
Engitix Therapeutics to relocate headquarters to new life sciences cluster, White City Place

10 December 2020
Crescendo Biologics Expands its Ongoing Collaboration with Takeda

08 December 2020
Forbion secures EUR 460 million for oversubscribed fifth fund

07 December 2020
HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability

07 December 2020
Rexgenero Appoints Sadia L’Baouch as Chief Manufacturing Officer

04 December 2020
SkinBioTherapeutics plc - Full year results 2020

03 December 2020
Enthera Pharmaceuticals appoints Kazumi Shiosaki to its Board of Directors and Lisa Olson to its Scientific Advisory Board to push forward company growth and development

01 December 2020
atbtherapeutics initiates agreement with iBio CDMO to manufacture game-changer atbodies to better treat cancer

01 December 2020
MammaPrint® named in first Breast Cancer Clinical Pathway published by Spanish Society of Senology and Breast Pathology (SESPM)

01 December 2020
Engitix Appoints Eduardo Bravo as Chairman of its Board of Directors

30 November 2020
HOOKIPA Announces Positive Phase 2 Interim Safety, Immunogenicity, and Efficacy Data for its Cytomegalovirus Vaccine Candidate HB-101

30 November 2020
Validant acquires IDEC, a leading regulatory consultancy in Japan

24 November 2020
Clinigen expands partnership with Accord Healthcare in Clinical Services into France

24 November 2020
Stephen Freer appointed Chief Clinical Officer at Ieso

20 November 2020
Rexgenero-France Announces New Approach to Viral Vector Quantitation Using Myriade’s Videodrop at AIS 2020

19 November 2020
Forbion invests in EUR 37M series A financing of SynOx Therapeutics

19 November 2020
NorthSea Therapeutics doses first patient in Phase 1 trial of SEFA-1024 in dyslipidemia and further expands its clinical pipeline

11 November 2020
Rexgenero-France to present Off-the-Shelf CAR-T Therapy nanoparticle data at PEGS Europe 2020

10 November 2020
Clinigen’s Totect® (dexrazoxane) receives FDA approval for new indication to treat incidence and severity of cardiomyopathy associated with doxorubicin in women with metastatic breast cancer

02 November 2020
Oxford BioDynamics announces strategic partnership with Boca Biolistics in order to advance EpiSwitch™ disease severity program for COVID-19

02 November 2020
Mission Therapeutics Appoints Dr Suhail Nurbhai as Chief Medical Officer

29 October 2020
HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-202/HB-201 Alternating Vector Therapy to Treat Human Papillomavirus16-Positive Cancers

28 October 2020
Oxford BioDynamics advances EpiSwitch™ disease severity program for COVID-19 with top US academic health center, Oregon Health & Science University

27 October 2020
Prilenia Enrolls First Patients into its PROOF-HD Phase 3 Clinical Trial for Huntington’s Disease in the United States

26 October 2020
Seventure Partners Life Sciences Corporate Update Health for Life: June – September 2020

26 October 2020
Rexgenero Announces Positive Outcome of Independent Data Monitoring Committee Meeting for Phase III Trial for Diabetic Patients with Critical Limb-Threatening Ischaemia

21 October 2020
MammaPrint® Approved for Reimbursement in Germany

20 October 2020
atbtherapeutics Strengthens its Scientific Advisory Board to Support the Development of its Novel Platform and Portfolio

19 October 2020
HOOKIPA Appoints Prof. Jean-Charles Soria, Director General of the Gustave Roussy Cancer Center in Paris, to its Board of Directors

15 October 2020
Touchlight appoints Karen Fallen as CEO of Touchlight DNA Services

14 October 2020
SkinBioTherapeutics plc - Proposed Placing to raise £4.0m - Open Offer to Qualifying Shareholders

13 October 2020
IONTAS announces Mammalian Display licensing agreement with Bristol Myers Squibb

13 October 2020
Feedback plc - Full Year Results to 31 May 2020 - Bleepa™ drives Feedback’s strategy in dynamic year of development

08 October 2020
Cytiva’s Fibro PrismA technology accelerates mAb purification in LifeArc’s Covid-19 research

08 October 2020
Merit launches Health division to meet £3.7bn Government plans for new hospitals, built offsite, with enhanced infection control

07 October 2020
Forbion portfolio company, Enterprise Therapeutics’ First-in-Class TMEM16A potentiator program for treatment of cystic fibrosis and other respiratory diseases acquired by Roche

06 October 2020
Agendia, HiSS Diagnostics and PathoNext offer local MammaPrint and BluePrint testing for breast cancer patients in Germany

05 October 2020
Xellia Pharmaceuticals Launches new doses of VANCO READYTM (Ready-to-use room temperature premixed vancomycin injection bags)

01 October 2020
Neuromodulation pioneer WISE closes EUR 15M Series C financing round to launch second product, SCS EXPERT, for chronic pain

29 September 2020
Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture

28 September 2020
IONTAS and FairJourney Biologics Discover SARS-CoV2 Neutralizing Antibodies with Picomolar Potency

22 September 2020
Synaffix Wins Best Platform Technology at 7th Annual World ADC Awards

21 September 2020
Forbion portfolio company, Inflazome to be acquired by Roche

18 September 2020
Microbiotica Wins Young Company of the Year at Business Weekly Awards

17 September 2020
Clinigen - Full Year Results - Double digit organic EBITDA growth delivered -- Platform in place for accelerated growth

16 September 2020
HOOKIPA Pharma’s LCMV-based Immunotherapy for HPV16+ Cancers Demonstrates High Immunogenicity, According to Peer Reviewed Article

16 September 2020
Cytiva launches Xcellerex Automated Perfusion System for more efficient manufacture of biotherapeutics

16 September 2020
Synaffix Sees Competitive Early In Vivo Data from ADCs Based on Proprietary Exatecan Linker-Payload

15 September 2020
First Patients Treated in First-in-Human Trial for ACTISEAL® – Polyganics’ Innovative Liver and Pancreas Sealant Patch

14 September 2020
5 years, 500 million USD, and nearly 1,000 people: Cytiva invests for global capacity expansion

10 September 2020
Henk Schuring joins Prilenia as Chief Regulatory and Commercialization Officer

09 September 2020
atbtherapeutics appoints Dr Werner Cautreels and Dr Vincent Brichard to its Board of Directors to foster development of its game-changing antibody-toxin-bioengineered ‘atbody’ therapeutics

08 September 2020
Forbion leads US$35M Series B financing round for Inversago Pharma

08 September 2020
SkinBioTherapeutics plc - Appointment of Senior Medical Advisor

02 September 2020
Xellia Pharmaceuticals expands approved doses of VANCO READYTM (Ready-to-Use Premixed Vancomycin Injection bags)

26 August 2020
Autifony Therapeutics regains rights to clinical stage Kv3 programme

25 August 2020
Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases

13 August 2020
HOOKIPA Pharma Reports Second Quarter 2020 Financial Results and Provides a Corporate Update

11 August 2020
Forbion portfolio company, KaNDy Therapeutics, to be acquired by Bayer

04 August 2020
ELITechGroup Molecular Diagnostics places 500th system, distributes 3.5 million SARS-CoV-2 tests

04 August 2020
Key Appointments Strengthen Mission Therapeutics’ Senior Management Team

31 July 2020
SkinBioTherapeutics plc - Product Development Progress

30 July 2020
Seventure’s Health for Life Capital II™ fund qualifies for French government’s financing initiative (“TIBI”) as first and only fund in the microbiome field

29 July 2020

28 July 2020
Enthera Pharmaceuticals raises €28 million in Series A financing to advance restorative therapy for type 1 diabetes and inflammatory bowel disease

23 July 2020
Synaffix Announces Expansion of Collaboration with ADC Therapeutics

22 July 2020
T3 Pharma raises 25M CHF to advance bacterial cancer therapy through clinic

21 July 2020
UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm

21 July 2020
Staten Biotechnology, in collaboration with Novo Nordisk, starts dosing of anti-apoC3 antibody SST-5058 in First-in-Human Trial

15 July 2020
Healx and Muscular Dystrophy UK join forces to find new treatments for rare muscle-wasting diseases

14 July 2020
Year end trading update July 2020

13 July 2020
Clinigen granted Orphan Drug Designation by the FDA for aldesleukin in the treatment of Amyotrophic Lateral Sclerosis (ALS)

09 July 2020
Forbion announces first close of Forbion Growth Opportunities Fund at EUR 185 million (USD 208 million)

08 July 2020
VarmX raises €32 million in Series B financing to develop innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants

07 July 2020
SkinBioTherapeutics plc Business Update July 2020

07 July 2020
Mission and Imperial College London Report Potent and Selective Probe for Deubiquitylating Enzyme UCHL1

06 July 2020
Mission Raises $15m and Expands its Relationship with Pfizer

02 July 2020
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief Medical Officer

24 June 2020
Cytiva upgrades Massachusetts contract biomanufacturing site with increased capacity and automation technologies

24 June 2020
BioGeneration Ventures closes BGV IV fund at €105 million

22 June 2020
HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB 101

22 June 2020
Rexgenero acquires the key technology and program assets of SAS Group

17 June 2020
HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers

17 June 2020
Meri Williams joins Healx as Chief Technology Officer

15 June 2020
Feedback plc: Placing to raise £5.05 million, Open Offer to raise up to £0.54 million and Notice of General Meeting

11 June 2020
The COVID-19 trade-off: UK public support relaxed vaccine regulations, but expect additional long-term checks

08 June 2020
Microbiotica, Cancer Research UK and Cambridge University Hospitals collaborate in landmark cancer microbiome study

05 June 2020
Touchlight’s Chairman to help lead UK Covid-19 vaccine effort

04 June 2020
Memo Therapeutics AG identifies potent SARS-CoV-2-neutralizing antibodies from the blood of recovered COVID-19 patients

03 June 2020
Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS

03 June 2020
Forbion leads $62.5m Series A fund raising for Prilenia Therapeutics

03 June 2020
GHO Capital Acquires X-Chem, the Leading Provider of DNA-Encoded-Library-Mediated Drug Discovery Services

02 June 2020
Mission Moves to New Babraham Campus Headquarters

01 June 2020
Bleepa® achieves CE Mark, raising the bar for medical communication platforms

01 June 2020
Seventure Partners Life Sciences Corporate Update Health for Life: January – April 2020

21 May 2020
Royal Papworth Hospital NHS Foundation Trust renews contract with Feedback and adopts Bleepa®

14 May 2020
Microbiotica Statement About Chairman Thomas Lynch

14 May 2020
HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update

14 May 2020
Nevro Announces CE Mark Approval of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain

14 May 2020
Clinigen signs exclusive agreement with Xeris Pharmaceuticals to supply and distribute Gvoke™ outside the US

13 May 2020
FairJourney Biologics joins forces with Iontas to create a global leader in outsourced antibody discovery services

13 May 2020
Polyganics Awarded €1.2 Million for Clinical Development of Liver and Pancreas Sealant Patch

13 May 2020
DNAe Technology Successfully Detects SARS-CoV-2 Sequences

12 May 2020
Xellia Pharmaceuticals recruiting additional >100 employees to expand workforce at its Cleveland, Ohio manufacturing site

11 May 2020
UK non-profit crowdfunding for new reusable, 3D-printed facemasks to sustainably tackle NHS PPE shortage

05 May 2020
Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Humabody® therapeutic

04 May 2020
RevoluGen Ltd. appoints Sir John Chisholm as Non-Executive Chairman

04 May 2020
Autifony Therapeutics announces commencement of a Phase I study of AUT00201, a novel Kv3 modulator for schizophrenia and hearing disorders

27 April 2020
Karus Therapeutics Announces New Data from Phase I Cancer Trial at AACR

27 April 2020
Touchlight appoints Dr. Helen Horton as Chief Research Officer

22 April 2020
Emergex Signs Agreement with George Mason University for Highly Pathogenic RNA Virus Studies

20 April 2020
Bleepa® rolled-out across Pennine Acute Hospitals NHS Trust to help manage the COVID-19 peak

16 April 2020
Clinigen signs exclusive global licensing and distribution agreement with Porton Biopharma to commercialise Erwinase® / Erwinaze®

16 April 2020
Synthon Biopharmaceuticals relaunches as Byondis

16 April 2020
Leading global antibody discovery companies FairJourney Biologics and Iontas announce partnership in search for SARS-CoV-2 treatment

15 April 2020
Healx partners with Children’s Tumor Foundation (CTF) to progress neurofibromatosis treatments; recruits patient advocate to lead collaborative drug discovery efforts

09 April 2020
FDA Grants Breakthrough Device Designation to DNAe’s Sequencing Diagnostic

06 April 2020
Healx using artificial intelligence to find combination drug treatments for COVID-19

01 April 2020
Introducing Cytiva – Global Life Sciences Leader

31 March 2020
AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI

26 March 2020
Feedback Medical to offer Bleepa to assist Coronavirus response

26 March 2020
Xellia Pharmaceuticals Obtains FDA Approval of Injectable Manufacturing Site in Cleveland, Ohio

19 March 2020
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update

10 March 2020
Kuur Therapeutics launches to develop and commercialize “off-the-shelf” CAR-NKT cell therapies targeting hematological and solid tumors

02 March 2020
GE Healthcare Life Sciences to manufacture RevoluGen’s Fire Monkey / Fire Flower product for enabling long-read DNA sequencing

27 February 2020
Confo Therapeutics to present at Cowen 40th Annual Health Care Conference

25 February 2020
Clinigen Half Year Results

19 February 2020
SkinBioTherapeutics signs agreement with Winclove Probiotics to develop psoriasis food supplement

18 February 2020
Interim Results for the six months to 30 November 2019

12 February 2020
Rexgenero Appoints Huw Jones as a Non-Executive Director

10 February 2020
Rexgenero Appoints David Horn Solomon as Chairman

04 February 2020
Healx appoints Dr Anthony Hall as Chief Medical Officer

03 February 2020
Adam Denning, Former Assistant Technical Advisor to Bill Gates, Appointed as Non-Executive Director

03 February 2020
Crescendo Biologics appoints Dr Kenji Hashimoto as Chief Medical Officer

30 January 2020
GHO Capital invests in FairJourney Biologics, a global leader in monoclonal antibody discovery services for biopharma

29 January 2020
Forbion Appoints Dr. John Montana as Operating Partner

23 January 2020
WISE completes enrolment in pivotal clinical study of novel neuro-electrodes for brain monitoring

16 January 2020
CLINIGEN_Half Year trading update

15 January 2020
Publication in Cancer Research demonstrates Crescendo Biologics’ Humabody® VH therapeutics outperform conventional antibodies in vivo

14 January 2020
Clinigen signs agreement with Iovance Biotherapeutics to supply Proleukin® (aldesleukin) for use in Tumor Infiltrating Lymphocyte (TIL) Clinical R&D

13 January 2020
Feedback plc licence agreement with Imaging Engineering

09 January 2020
Biofidelity and Agilent complete successful molecular assay study for rapid and accurate detection of key lung cancer mutations

09 January 2020
GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma

09 January 2020
Emergex raises more than US$11 million in a Series A Round to Progress its Pipeline of Set-point Vaccines for Infectious Diseases

08 January 2020
NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA study in NASH and to Advance Two Additional SEFAs into the Clinic

07 January 2020
Synaffix announces expansion of license agreement with Shanghai Miracogen Inc. to a second ADC candidate

07 January 2020
Polyganics Achieves CE Mark Certification for LIQOSEAL®

06 January 2020
Clinigen and Orphazyme launch an Early Access Program for arimoclomol in patients with Niemann-Pick disease type C

06 January 2020
HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry